October 9, 2019
British artificial intelligence (AI) firm Sensyne Health has entered a formal research agreement with the UK Medicines and Healthcare products Regulatory Agency (MHRA) to help develop methods to validate software algorithms used in digital health.
The firm announced the collaboration in its annual report for the year ending April 2019, which was published this week.
Sensyne also revealed it has...
May 7, 2019
Life sciences giant Bayer has joined forces with clinical AI technology company Sensyne Health to help develop a national linked patient data capability.
The German firm has signed a memorandum of understanding to be the preferred pharmaceutical partner in a consortium, which includes Microsoft, EY, JP Morgan, and Peel Hunt.
The consortium aims to accelerate the discovery and development of new...
November 21, 2018
Oxford-based Sensyne Health announces partnership with EY. Former UK science minister Lord (Paul) Drayson’s Sensyne Health has signed a Strategic Advisory Services agreement with EY to scale up the business and build on its business model. The company has inked partnerships with three NHS trusts in England to analyse anonymised patient data using its clinical AI technology to accelerate medical...